Thinking of Buying Valeant? Consider These 2 Stocks Instead

These two companies also have a remarkable track record, but aren’t quite as polarizing.

There is perhaps no other company in Canada as polarizing as Valeant Pharmaceuticals (TSX: VRX)(NYSE: VRX). As an example, two famous hedge fund investors in the United States, Bill Ackman (who owns a sizable stake) and Jim Chanos (who is betting against the company), disagree on where the stock price is headed. Both of them are very well respected, but at least one of them will be wrong about Valeant.

If you’re thinking of siding with Mr. Ackman, then it’s clear that a strong management track record is more important to you than a company’s transparency. You’re also willing to pay a premium price for a company that’s performing well. So with that in mind, you may want to consider these two names instead.

1. Brookfield Asset Management

Like Valeant, shares of Brookfield Asset Management (TSX: BAM.A)(NYSE: BAM) have done extraordinarily well, returning 19% per year over the past 20 years. Over a time period this long, you can’t claim that luck is involved; such a track record can only come from buying and selling assets smartly.

Also like Valeant, Brookfield is a very difficult company to figure out, with numerous moving parts and changes to its organizational structure. Investors who own the stock are owning it for its track record.

Fortunately, Brookfield is not so expensive. After adjusting for the public companies it owns, it trades at only about 15 times forward earnings.

2. Constellation Software

Anyone who has owned Constellation Software (TSX: CSU) for five years or more has been richly rewarded. The company originally became public back in 2006 at less than $20 per share, and eight years later now trades at nearly $250.

The company’s success comes from CEO Mark Leonard and his management team smartly buying up software companies, typically for under $5 million, and them letting run on their own. Needless to say, it’s worked wonders.

As a bonus, there aren’t the same transparency issues with Constellation that come with Brookfield and Valeant; the company is very straightforward with investors. Unfortunately, Constellation’s shares are very expensive. Last year, the company made $4.39 per share in income and just under $10 per share in free cash flow. These are fairly small numbers for a company with a $247 share price. But if the company can continue to grow as it has in the past, then the shares are undervalued.

Fool contributor Benjamin Sinclair holds no positions in any of the stocks mentioned in this article. Tom Gardner owns shares of Valeant Pharmaceuticals. The Motley Fool owns shares of Valeant Pharmaceuticals.

More on Investing

woman stares at chocolate layer cake
Dividend Stocks

Power Corporation vs. Great-West Lifeco: Which Dividend Stock Would I Own?

Power Corporation gives you exposure to Great-West and more. I’d take Great-West directly when I want to know what’s funding…

Read more »

frustrated shopper at grocery store
Tech Stocks

Shopify Stock Is Down 16% in the Past Month: Should You Buy the Dip?

Shopify stock fell 16% recently. Discover the impact of interest rate hikes and market sentiment on Shopify's performance.

Read more »

dividend growth for passive income
Energy Stocks

Enbridge Has a New CEO and 31 Straight Dividend Hikes: Worth Buying?

With a new CEO taking charge, 31 consecutive annual dividend increases, and a $38 billion growth backlog, Enbridge could be…

Read more »

hot air balloon in a blue sky
Bank Stocks

Hot Take: This Is the Top Canadian Dividend Stock for Safety and Growth

Here's a safe Canadian dividend stock for investors seeking reliable income, financial stability, and long-term growth.

Read more »

a person watches a downward arrow crash through the floor
Dividend Stocks

Down Day, Wish List Ready: 3 Canadian Stocks to Keep Handy If You Have Cash to Invest

Market swings can catch you off guard, but be ready to take advantage of buying opportunities in a down day.

Read more »

View of high rise corporate buildings in the financial district of Toronto, Canada
Stocks for Beginners

Stantec Stock: Turning Infrastructure Spending Into a Long-Term Investment Case

A bigger infrastructure budget makes a good headline. Stantec’s backlog and earnings tell me whether shareholders are starting to benefit.

Read more »

Canadian Red maple leaves seamless wallpaper pattern
Dividend Stocks

How I’d Use a $20,000 TFSA to Start an Income Plan, Not Replace a Salary

A $20,000 TFSA can start paying part of a bill. Reinvesting those first dividends can give it a bigger job…

Read more »

A solar cell panel generates power in a country mountain landscape.
Investing

3 Top Canadian Stocks to Buy With $1,000

These Canadian stocks have solid growth prospects and are likely to outperform the broader Canadian equity market by a wide…

Read more »